ReneuralTM has raised £200K in a pre-seed funding round led by SFC Capital, with an additional £275K in support from Innovate UK.  Reneural Technologies Limited, formerly known as CardioCrown, is addressing the critical gap in effective and continuous rehabilitation for stroke survivors with its innovative approach to enhance patient outcomes, reduce clinician burnout, and lowes healthcare costs. The company facilitates early discharge from hospitals, improves patient engagement and compliance, while enabling efficient remote care.